| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |